NCT05962424View on ClinicalTrials.gov

HNC: Human Neural Circuits Electrophysiology During Cognition

PHASE1RecruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

October 5, 2023

Primary Completion Date

September 1, 2030

Study Completion Date

September 1, 2030

Conditions

Psychiatric Disorder

Interventions

DRUG

Ketamine Hydrochloride

Ketamine is an FDA-approved dissociative anesthetic.

Trial Locations (1)

94306

RECRUITING

Stanford University, Palo Alto

All Listed Sponsors

lead

Stanford University

OTHER